Product Program year 2025 Source: CMS Open Payments

SpyGlass

Device SpyGlass_ENDO

PDI 08714729764441

Open in the dashboard

General payments

$447,119

4,305 payments

Research payments

$23,718

7 payments

Through program year 2025, $447,119 in general payments and $23,718 in research payments were reported against SpyGlass (SpyGlass_ENDO).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $145,246 1,199
2024 General $42,763 463
2024 Research $23,718 7
2023 General $68,486 963
2022 General $172,754 1,661
2021 General $17,870 19

Breakdown

Who paid General payments · program years 2021–2025
  1. Boston Scientific Corporation $447,119 4,305 payments
Top recipients General payments · program year 2025
  1. Rabia Latour New York, NY $2,483 2% · 16 payments
  2. Shaya Noorian Internal Medicine · Los Angeles, CA $2,227 2% · 11 payments
  3. Romik Srivastava Gastroenterology · Charleston, SC $2,055 1% · 10 payments
  4. Alyssa Grossen Gastroenterology · New Haven, CT $1,925 1% · 10 payments
  5. David Carr Locke Gastroenterology · New York, NY $1,887 1% · 10 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Gastroenterology Internal Medicine $97,590 75% · 282 practitioners
  2. Internal Medicine $14,525 11% · 20 practitioners
  3. Surgery $12,070 9% · 15 practitioners
  4. Pediatrics $1,745 1% · 1 practitioner
  5. Pediatric Gastroenterology Pediatrics $1,340 1% · 2 practitioners

The top 5 of 27 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $20,704 14% · 34 recipients
  2. California $19,156 13% · 34 recipients
  3. Florida $15,530 11% · 25 recipients
  4. Texas $10,213 7% · 34 recipients
  5. Massachusetts $7,893 5% · 20 recipients

The top 5 of 41 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

4,305 general · 7 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record